Alibaba
BABA
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
Apple
AAPL
US Stock MarketDetailed Quotes
SCLX Scilex Holding
- 0.354
- +0.005+1.55%
Close Feb 14 16:00 ET
- 0.360
- +0.006+1.69%
Post 20:01 ET
86.13MMarket Cap-0.44P/E (TTM)
0.360High0.342Low1.17MVolume0.350Open0.349Pre Close411.54KTurnover0.65%Turnover RatioLossP/E (Static)243.31MShares2.63052wk High-0.41P/B63.80MFloat Cap0.33052wk Low--Dividend TTM180.22MShs Float16.900Historical High--Div YieldTTM4.91%Amplitude0.330Historical Low0.351Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Scilex Holding Stock Forum
7 MINUTES AGO, 4:00 PM EST
VIA GLOBENEWSWIRE
NEW YORK, NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust Account") an aggregate of $15,063.74 to fund the one-month extension from February 11, 2025 to Mar...
D. Boral Capital Initiates Coverage On Scilex Holding with Buy Rating, Announces Price Target of $22
Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication
Wednesday, 22nd January at 8:00 am
PALO ALTO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ: SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute ...
Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC
Tuesday, 21st January at 9:00 am
PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ: SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the t...
2 min ago
Scilex Holding Company Announces That It Will Be Filing Today of a Supplemental New Drug Application With the FDA for Elyxyb® in Acute Pain Indication
Scilex Holding Company Announces that It Will Be Filing Today of a Supplemental New Drug Application with the FDA for ELYXYB® in Acute Pain Indication
Tuesday, 21st January at 7:00 am
ELYXYB®, a rapid onset and ready-to-use formulation of Celecoxib, delivers a first line non-opioid therapeutic alternative to habit-forming opioids and acetaminophen, the leading cause of acute liver failure in the U.S.(1)
DelveInsight estimates there were approximately 100 million ca...
No comment yet